Moderate Diabetic Retinopathy: What You Need to Know
Understanding Moderate NPDR
Moderate nonproliferative diabetic retinopathy, often called moderate NPDR, is the second of four nonproliferative stages of diabetic retinopathy. It represents meaningful damage to the retinal blood vessels but has not yet reached the most dangerous stages. Knowing what is happening inside the eye at this point helps you understand why regular monitoring matters so much.
Diabetic retinopathy is a complication of diabetes that damages the tiny blood vessels supplying the retina, the light-sensitive tissue at the back of the eye. At the moderate NPDR stage, a retina specialist can see specific signs of vessel damage during an eye exam. These include microaneurysms (tiny bulges in blood vessel walls), dot-and-blot hemorrhages (small areas of bleeding within the retina), cotton-wool spots (fluffy white patches from reduced blood flow), and hard exudates (yellowish deposits from leaked fluid).
These findings confirm that retinal blood vessels are weakening and that the disease has progressed beyond the earliest stage.
Chronic high blood sugar damages two important types of cells within retinal blood vessels: pericytes, which support and stabilize vessel walls, and capillary endothelial cells, which line the vessels. When these cells are injured, the vessels become weak and leaky.
This damage involves pathways related to inflammation and oxidative stress. Over time, the blood-retinal barrier, which normally prevents fluid and proteins from seeping into retinal tissue, begins to break down. When it fails, fluid enters the retina and can cause swelling. Progressive damage also reduces blood flow to parts of the retina, a condition known as retinal ischemia.
Diabetic retinopathy progresses through four nonproliferative stages followed by one proliferative stage. Mild NPDR involves only a few microaneurysms. Moderate NPDR shows more widespread damage, including hemorrhages and cotton-wool spots, but does not yet meet the criteria for severe NPDR. Severe NPDR involves extensive bleeding, vein abnormalities, and widespread areas of poor blood flow throughout the retina.
The most advanced stage, proliferative diabetic retinopathy (PDR), occurs when abnormal new blood vessels grow on the retinal surface. These fragile vessels can bleed and lead to serious vision loss. Eyes with moderate NPDR carry a meaningful risk of progressing to PDR within five years, which is why consistent monitoring is essential.
Who Is at Risk
Anyone with type 1 or type 2 diabetes can develop diabetic retinopathy, but some people face a higher risk than others. Understanding the factors involved helps explain why certain patients need more frequent monitoring and why managing overall health is so closely tied to eye health.
Diabetic retinopathy is one of the most common complications of diabetes and a leading cause of vision loss among working-age adults. Millions of people in the United States are living with some degree of diabetic retinopathy, representing a significant portion of those with diabetes overall.
The two most important risk factors are how long a person has had diabetes and how well blood sugar has been controlled over time. After many years with diabetes, the majority of patients with type 1 diabetes and a substantial number with type 2 diabetes develop some degree of retinopathy. Poor glycemic control, reflected in elevated HbA1c levels, accelerates damage to retinal blood vessels.
Several additional conditions can increase the risk of developing or worsening moderate NPDR. Some of these are manageable with the right medical care.
- High blood pressure (hypertension)
- High cholesterol and abnormal lipid levels (dyslipidemia)
- Kidney disease related to diabetes (diabetic nephropathy)
- Pregnancy, which can accelerate retinopathy progression
- Smoking, which damages blood vessels and reduces oxygen delivery to the retina
People who have had diabetes for many years, those with uncontrolled blood sugar, and individuals with other diabetes-related complications should be especially attentive to their eye health. Pregnant women with diabetes should have a dilated eye exam early in pregnancy and continue to be monitored throughout, as retinopathy can progress more quickly during this time.
Signs and Symptoms
One of the most challenging aspects of moderate NPDR is that many people feel no different from usual. Vision problems may not appear until the disease has advanced significantly. This makes routine eye exams critical even when everything seems fine.
The damage at this stage occurs within the retinal blood vessels, not always in the area responsible for sharp central vision. Many people with moderate NPDR have no noticeable symptoms at all. Because the eyes can look and feel normal, people sometimes assume there is nothing wrong. Regular dilated eye exams are the only reliable way to detect this stage of disease.
As moderate NPDR progresses, or if diabetic macular edema (swelling of the central retina) develops alongside it, some people begin to notice vision changes. These symptoms are important to report to your eye care provider right away.
- Blurred vision that comes and goes
- Spots or dark strings floating in the field of vision, called floaters
- Dark or empty areas in the vision
- Difficulty seeing in low light or at night
- Vision that fluctuates from day to day
Certain symptoms require urgent medical attention and should not be waited on until a scheduled appointment. If you experience a sudden increase in floaters, flashes of light, a shadow or curtain appearing over part of your vision, or sudden vision loss in one eye, contact a retina specialist or go to the emergency room immediately. These symptoms may indicate a serious complication such as a retinal detachment or bleeding inside the eye.
Diagnosis and Testing
Diagnosing moderate NPDR requires a thorough eye evaluation using several tools. These tests allow a retina specialist to see the retina in detail, measure its health, and track changes over time. Most are painless and performed right in the office.
The most important step in detecting moderate NPDR is a comprehensive dilated eye exam. Drops are placed in the eyes to widen the pupils, allowing the retina specialist to look directly at the retina and evaluate the blood vessels. The specialist looks for microaneurysms, hemorrhages, cotton-wool spots, and hard exudates that confirm the diagnosis of moderate NPDR.
Optical coherence tomography (OCT) is a noninvasive imaging test that creates detailed cross-sectional images of the retina. It allows a retina specialist to measure retinal thickness and detect fluid or swelling with great precision. OCT is especially useful for identifying diabetic macular edema, which can develop alongside moderate NPDR and affect central vision. The test takes only a few minutes and involves no injections or direct contact with the eye.
Fluorescein angiography uses a special dye to map the retinal blood vessels in detail. A small amount of fluorescein dye is injected into a vein in the arm, and as it travels through the retinal vessels, a camera takes rapid photographs. This test reveals areas of leaking vessels, poor blood flow, and abnormal vessel growth. It helps the retina specialist assess disease severity and guide treatment decisions.
Ultra-widefield imaging captures a broad view of the entire retina in a single photograph. Standard retinal cameras show only a limited portion of the retina, but ultra-widefield technology can capture up to 200 degrees of the retinal surface. This wider view helps detect damage in the outer edges of the retina that might be missed with conventional imaging.
Treatment Options
Treatment for moderate NPDR depends on the severity of retinal changes, whether macular edema is present, and how well systemic health factors such as blood sugar and blood pressure are being managed. Your retina specialist will tailor a plan based on your individual findings.
For moderate NPDR, managing the underlying diabetes is the most critical step in slowing disease progression. Keeping blood sugar levels within target ranges, with a goal HbA1c below 7% when medically appropriate, has been shown to significantly reduce the risk of worsening retinopathy. Controlling blood pressure and managing cholesterol levels are equally important parts of protecting the retinal blood vessels.
Working closely with your primary care provider or endocrinologist to optimize these systemic factors can make a meaningful difference in the long-term health of your eyes.
For moderate NPDR without diabetic macular edema, the standard approach is careful observation combined with systemic health management. Follow-up visits are typically scheduled every six to eight months. At each visit, a retina specialist performs a dilated exam and imaging tests to track any changes.
The goal of monitoring is to detect any worsening early so that treatment can begin promptly if needed. Because moderate NPDR can progress without producing noticeable symptoms, staying on schedule with these appointments is essential.
Anti-VEGF agents block vascular endothelial growth factor (VEGF), a protein that drives abnormal blood vessel growth and leakage in the retina. These medications are delivered through an intravitreal injection, meaning they are injected directly into the vitreous (the gel-like space inside the eye). The eye is numbed beforehand, and the procedure takes only seconds. Most patients feel pressure rather than sharp pain, and any mild discomfort afterward typically resolves within a day or two.
Several anti-VEGF medications are approved for diabetic retinopathy, including aflibercept (Eylea), ranibizumab (Lucentis), and faricimab (Vabysmo), which targets both VEGF and a second protein called angiopoietin-2. Bevacizumab (Avastin) is also used in some cases. Anti-VEGF therapy is most commonly used when macular edema is present or when the disease progresses, though it may be considered for select cases of moderate NPDR based on individual risk.
Laser photocoagulation, a procedure that uses a focused beam of light to seal leaking blood vessels or treat areas of poor blood flow, has been used for diabetic retinopathy for decades. For moderate NPDR without macular edema, laser is generally not the first-line approach. However, if the disease advances to more severe or proliferative stages, laser therapy may become part of the treatment plan. Your retina specialist will advise whether and when laser treatment is appropriate for your specific situation.
Living With Moderate NPDR
A diagnosis of moderate NPDR calls for active participation in your own care. The steps you take every day, from how you manage blood sugar to whether you keep your scheduled appointments, directly affect your long-term vision outcomes. Our team is here to support you through every stage of this process.
Maintaining good blood sugar control is the single most important thing you can do to protect your vision. Work with your diabetes care team to keep your HbA1c within your target range. Even modest improvements in blood sugar management can slow the progression of retinopathy, reduce the likelihood of needing more intensive treatments, and support better health overall.
High blood pressure places extra stress on already weakened retinal blood vessels. Keeping blood pressure within a healthy range helps protect these vessels from further damage. Similarly, managing cholesterol and lipid levels reduces the risk of blood vessel problems throughout the body, including the eyes. These factors are closely connected to the health of your retina.
Healthy daily habits reinforce your medical treatment plan and support your overall diabetes management. Regular moderate physical activity helps control blood sugar, blood pressure, and weight. A balanced diet rich in vegetables, fruits, whole grains, and lean proteins supports metabolic health. If you currently smoke, quitting is one of the most impactful changes you can make for your eyes and your overall health.
Receiving a diagnosis of moderate NPDR can feel overwhelming or frightening. It is completely normal to feel anxious about your vision. Staying informed about your condition, attending all scheduled appointments, and communicating openly with your care team can help you feel more in control. Many patients also find it helpful to connect with diabetes support groups or mental health counseling services for additional guidance.
Frequently Asked Questions
Here are answers to some of the most common questions patients have after a diagnosis of moderate NPDR, covering topics that go beyond what is addressed in the sections above.
While moderate NPDR is generally a progressive condition, improvement is possible in some patients. Clinical trials involving anti-VEGF therapy have shown that a meaningful percentage of patients experience improvement on the diabetic retinopathy severity scale, particularly with consistent treatment. Strict blood sugar, blood pressure, and cholesterol management also support stabilization. The degree of improvement varies from person to person, and your retina specialist will help set realistic expectations based on your specific findings.
Not necessarily. Many patients with moderate NPDR who do not have diabetic macular edema are managed successfully through observation and systemic health control alone for extended periods. Injections are typically recommended when the disease progresses to a more advanced stage, when macular edema develops, or when your retina specialist determines the risk of progression warrants earlier intervention. The decision is always individualized and based on your imaging results and overall health picture.
Moderate NPDR refers to the stage of retinopathy based on the extent of blood vessel damage throughout the retina. Diabetic macular edema (DME) is a separate but related condition in which fluid leaks into the macula, the central area of the retina responsible for detailed vision. DME can occur at any stage of diabetic retinopathy, including moderate NPDR. It is one of the most common causes of vision loss in people with diabetes and is typically treated more aggressively than moderate NPDR alone.
Before your appointment, plan for your pupils to remain dilated for several hours afterward. Your vision will be blurry and your eyes sensitive to light during this time, so you should not drive yourself home. Bringing a pair of sunglasses will help with light sensitivity. If you wear contact lenses, bring your glasses as a backup. Arrive having eaten normally and having taken your usual medications, including any for blood sugar management, unless your care team advises otherwise.
For most people with moderate NPDR, regular moderate exercise is not only safe but actively beneficial. Physical activity supports blood sugar control, blood pressure management, and cardiovascular health, all of which help protect the retina. If your retinopathy progresses to a more advanced stage, particularly proliferative diabetic retinopathy, there may be specific activities to avoid due to the risk of triggering a bleed inside the eye. Always discuss exercise guidelines with your retina specialist if you have any concerns or if your disease status changes.
Most day-to-day fluctuations in vision related to blood sugar levels are not emergencies, though they should still be reported at your next scheduled visit. However, a sudden and significant increase in floaters, new flashes of light, a dark curtain or shadow moving across your vision, or sudden loss of vision in one eye are warning signs that require same-day evaluation. Do not wait for a scheduled appointment if these symptoms occur. Contact our office immediately or go to the nearest emergency room.
Schedule Your Evaluation at Rhode Island Eye Institute
If you have been diagnosed with moderate diabetic retinopathy, or if you have diabetes and have not had a dilated eye exam recently, our team is here to help. At Rhode Island Eye Institute, our retina specialists Dr. Gaurav Gupta and Dr. Pranjal Thakuria bring focused expertise and advanced diagnostic technology to every patient visit. We are committed to protecting your vision through precise monitoring, personalized care, and a genuine partnership in your long-term eye health. Contact us today to schedule your appointment at one of our convenient locations across Rhode Island and southeastern Massachusetts.